Device
Electromagnetic transduction therapy (EMTT)
Electromagnetic transduction therapy (EMTT) is a medical device with 2 clinical trials. Currently 2 active trials ongoing.
Total Trials
2
Max Phase
—
Type
DEVICE
Molecule
—
Success Metrics
Active Trials
2(100%)
Phase Distribution
Ph not_applicable
2
100%
Phase Distribution
0
Early Stage
0
Mid Stage
0
Late Stage
Phase Distribution2 total trials
N/ANon-phased studies
2(100.0%)
Highest Phase Reached
UnknownTrial Status & Enrollment
Completion Rate
0.0%
0 of 0 finished
Non-Completion Rate
0.0%
0 ended early
Currently Active
2
trials recruiting
Total Trials
2
all time
Status Distribution
Active(2)
Detailed Status
Active, not recruiting2
Development Timeline
Analytics
Development Status
Total Trials
2
Active
2
Success Rate
N/A
Most Advanced
N/A
Trials by Phase
N/A2 (100.0%)
Trials by Status
active_not_recruiting2100%
Recent Activity
2 active trials
Showing 2 of 2
active_not_recruitingnot_applicable
Focused Shockwave (ESWT), Radial Pressure Waves (EPAT), And Electromagnetic Transduction Therapy (EMTT) For Lower Extremity Musculoskeletal Injuries
NCT07526753
active_not_recruitingnot_applicable
Electromagnetic Transduction Therapy on Osteoarthritis in the Foot and Ankle
NCT06696118
Clinical Trials (2)
Showing 2 of 2 trials
NCT07526753Not Applicable
Focused Shockwave (ESWT), Radial Pressure Waves (EPAT), And Electromagnetic Transduction Therapy (EMTT) For Lower Extremity Musculoskeletal Injuries
NCT06696118Not Applicable
Electromagnetic Transduction Therapy on Osteoarthritis in the Foot and Ankle
All 2 trials loaded
Drug Details
- Intervention Type
- DEVICE
- Total Trials
- 2